Page 2 - Gthp News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Gthp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Gthp Today - Breaking & Trending Today
Guided Therapeutics, Inc. (OTCMKTS:GTHP – Get Rating) was the recipient of a significant decline in short interest in the month of April. As of April 15th, there was short interest totalling 100 shares, a decline of 96.9% from the March 31st total of 3,200 shares. Based on an average trading volume of 17,300 shares, the […] ....
Guided Therapeutics, Inc. (OTCMKTS:GTHP – Get Rating) saw a significant decrease in short interest during the month of April. As of April 15th, there was short interest totalling 100 shares, a decrease of 96.9% from the March 31st total of 3,200 shares. Based on an average daily volume of 17,300 shares, the days-to-cover ratio is […] ....
Guided Therapeutics, Inc. (OTCMKTS:GTHP – Get Rating) was the target of a significant growth in short interest in March. As of March 31st, there was short interest totalling 3,200 shares, a growth of 18.5% from the March 15th total of 2,700 shares. Based on an average daily volume of 33,200 shares, the short-interest ratio is […] ....
Guided Therapeutics (OTCMKTS:GTHP – Get Rating) and AxoGen (NASDAQ:AXGN – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability. Analyst Recommendations This is a breakdown of current recommendations for […] ....
Guided Therapeutics (OTCMKTS:GTHP – Get Rating) and Fc Global Realty (OTCMKTS:FCRE – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, analyst recommendations, risk, dividends and valuation. Insider & Institutional Ownership 9.8% of Guided Therapeutics […] ....